Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Details)

v3.22.2.2
Restatement of Previously Issued Financial Statements (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2019
Dec. 31, 2021
Dec. 31, 2020
Condensed Consolidated Statement of Operations                  
Total Operating Revenue $ 248,260,073 $ 156,185,955     $ 791,258,378 $ 452,070,338      
Medical Expenses 254,776,548 161,328,123     788,045,718 458,333,145      
Total Operating Expenses 308,272,010 184,309,497     1,815,625,200 519,153,369      
Operating Loss (60,011,937) (28,123,542)     (1,024,366,822) (67,083,031)      
Interest Expense, net (2,749,681) (2,529,133)     (8,244,806) (7,023,187)      
Total Other Expenses (5,317,104) (3,930,819)     (4,858,412) (19,086,452)      
Net Loss Attributable to Non-Controlling Interests (54,155,858)       (853,124,598)        
Net Loss (formerly Net Loss Attributable to Controlling Interests) (11,173,183) (32,054,361)     (176,100,636) (86,169,483)      
Condensed Consolidated Statement of Changes in Members' Deficit                  
Net Loss (65,329,041) (32,054,361) $ (29,464,410) $ (24,650,712) (1,029,225,234) (86,169,483)      
Balance at the end 78,076,015 (215,007,793) (183,308,520) (154,407,902) 78,076,015 (215,007,793)   $ 273,551,441 $ (130,217,705)
Condensed Consolidated Statement of Cash Flows                  
Net Loss (65,329,041) (32,054,361) $ (29,464,410) $ (24,650,712) (1,029,225,234) (86,169,483)      
Health Plan Settlements Receivable/Premiums Receivable           (884,523)      
Capitated Revenue                  
Condensed Consolidated Statement of Operations                  
Total Operating Revenue 243,988,004 153,072,995     780,775,285 443,598,050      
Condensed Consolidated Statement of Cash Flows                  
Total RAF adjustments         6,532,954        
Other Patient Service Revenue                  
Condensed Consolidated Statement of Operations                  
Total Operating Revenue $ 4,272,069 $ 3,112,960     $ 10,483,093 $ 8,472,288      
Class A and Class D Units                  
Condensed Consolidated Statement of Changes in Members' Deficit                  
Preferred return         8.00%        
Class A Preferred Units                  
Condensed Consolidated Statement of Changes in Members' Deficit                  
Preferred return   8.00% 8.00% 8.00%   8.00% 8.00%    
As Previously Reported                  
Condensed Consolidated Statement of Operations                  
Total Operating Revenue   $ 156,520,255       $ 459,503,232      
Medical Expenses   161,662,423       459,233,085      
Total Operating Expenses   184,643,797       520,053,309      
Operating Loss           (60,550,077)      
Interest Expense, net   (4,643,254)       (13,130,628)      
Total Other Expenses   (6,044,940)       (25,193,893)      
Net Loss Attributable to Non-Controlling Interests   (2,801,965)       (8,043,678)      
Net Loss (formerly Net Loss Attributable to Controlling Interests)   (31,366,517)       (77,700,292)      
Condensed Consolidated Statement of Changes in Members' Deficit                  
Net Loss   (34,168,482) $ (24,967,931) $ (26,607,560)   (85,743,970)      
Balance at the end   (179,246,686) (146,395,455) (122,918,168)   (179,246,686)     (97,661,735)
Condensed Consolidated Statement of Cash Flows                  
Net Loss   (34,168,482) (24,967,931) (26,607,560)   (85,743,970)      
Health Plan Settlements Receivable/Premiums Receivable           (7,417,477)      
As Previously Reported | Capitated Revenue                  
Condensed Consolidated Statement of Operations                  
Total Operating Revenue   152,276,992       447,137,121      
As Previously Reported | Other Patient Service Revenue                  
Condensed Consolidated Statement of Operations                  
Total Operating Revenue   4,243,263       12,366,111      
As Previously Reported | Class A and Class D Units                  
Condensed Consolidated Statement of Cash Flows                  
Class A and Class D Preferred Returns           6,107,441      
As Previously Reported | Class A Preferred Units                  
Condensed Consolidated Statement of Changes in Members' Deficit                  
Preferred Return at 8%   962,163 926,852 890,612   2,779,619      
Network Adjustments                  
Condensed Consolidated Statement of Operations                  
Net Loss Attributable to Non-Controlling Interests   2,801,965       8,043,678      
Net Loss (formerly Net Loss Attributable to Controlling Interests)   (2,801,965)       (8,043,678)      
Preferred Returns Adjustments                  
Condensed Consolidated Statement of Operations                  
Interest Expense, net   2,114,121       6,107,441      
Total Other Expenses   2,114,121       6,107,441      
Net Loss (formerly Net Loss Attributable to Controlling Interests)   2,114,121       6,107,441      
Condensed Consolidated Statement of Changes in Members' Deficit                  
Net Loss   2,114,121 2,036,476 1,956,848   6,107,441      
Balance at the end   7,895,224 6,743,106 5,633,581   7,895,224     4,567,346
Condensed Consolidated Statement of Cash Flows                  
Net Loss   2,114,121 2,036,476 1,956,848   6,107,441      
Preferred Returns Adjustments | Class A and Class D Units                  
Condensed Consolidated Statement of Cash Flows                  
Class A and Class D Preferred Returns           (6,107,441)      
Preferred Returns Adjustments | Class A Preferred Units                  
Condensed Consolidated Statement of Changes in Members' Deficit                  
Preferred Return at 8%   (962,163) (926,852) (890,612)   (2,779,619)      
Class A Units Adjustments                  
Condensed Consolidated Statement of Changes in Members' Deficit                  
Balance at the end   (43,656,331) (43,656,170) (43,656,269)   (43,656,331)     (43,656,270)
Revenue Adjustments                  
Condensed Consolidated Statement of Operations                  
Total Operating Revenue   (334,300)       (7,432,894)      
Medical Expenses   (334,300)       (899,940)      
Total Operating Expenses   (334,300)       (899,940)      
Operating Loss           (6,532,954)      
Net Loss (formerly Net Loss Attributable to Controlling Interests)           (6,532,954)      
Condensed Consolidated Statement of Changes in Members' Deficit                  
Net Loss     (6,532,955)     (6,532,954)      
Balance at the end       $ 6,532,954         $ 6,532,954
Condensed Consolidated Statement of Cash Flows                  
Net Loss     $ (6,532,955)     (6,532,954)      
Health Plan Settlements Receivable/Premiums Receivable           6,532,954      
Revenue Adjustments | Capitated Revenue                  
Condensed Consolidated Statement of Operations                  
Total Operating Revenue   796,003       (3,539,071)      
Revenue Adjustments | Other Patient Service Revenue                  
Condensed Consolidated Statement of Operations                  
Total Operating Revenue   $ (1,130,303)       $ (3,893,823)